Analyse Swot d'IBA

Résumé du document

In this document, we analyze the strengths and characteristics of IBA, the world's leading developer of particle therapy systems. IBA's experience, expertise and their client's satisfaction have turned it into the world's leading developer of particle therapy systems. Their strength lies in possessing a very important database of information, thanks to their large customer base and partnership. They also adapt to new technologies and are quite updated in their processes.

Extraits

[...] Collaboration with the entire European Union countries. Was handed an award for the contract related to the design, building, financing and operating of a Particle Therapy Centre in Essen, Germany Public Private partnership. Configuration of the Particle Therapy systems to match the requirements and budget of any oncology program. Prowess at converting clinical objectives into clinical applications of technology. Highly qualified workers experts and high trained staff High salary high personal costs Diversity of customers too much diversity procures a lot of work possibility to lose the main priorities Dependence on certain key employees high skilled 95% of the revenues are from exports The first crucial factor is trust might be too risky Dependence on a specific customer or on a limited number of orders - Opportunities Development of green technology Growing worldwide demand (Cancer is the leading cause of death worldwide, with Existence of other markets like Africa, South America IBA financial solutions available for new external ideas New areas in which they can develop new techniques Availability of the Proton Therapy technology Growing number of patients easier, faster & lower risk of access to the therapy. [...]

[...] Analyse Swot d'IBA SWOT ANALYSIS Strengths Weaknesses Worldwide industry. IBA's experience, expertise and their client's satisfaction have turned IBA into the world's leading developer of Particle Therapy systems. They detain a very important database of information thanks to their large customer base and partnerships. Technology up-to-date. Development of innovations thanks to years of research and clinical collaboration with leading cancer institutions around the world. [...]